Elinor Miller

2.2k citations
19 papers · 1.7k indexed · 1 hit paper · h-index 11
Topics
Lipoproteins and Cardiovascular Health (17 papers)Cancer, Lipids, and Metabolism (8 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers)

In The Last Decade

Elinor Miller

18 papers receiving 1.7k citations

Hit Papers

Comparison of the efficacy and safety of rosuvastatin ver...200320262010201820032505007501000

Peers

Elinor Miller
Comparison fields: 5 of 95
  • Surgery 1.4k
  • Economics and Econometrics 599
  • Endocrinology, Diabetes and Metabolism 567
  • Cancer Research 352
  • Cardiology and Cardiovascular Medicine 282
Replace James W. Blasetto with:
James W. Blasetto United States
Lorenzo Melani Italy
Irene Laurora United States
Phillip D. Toth United States
Alexandre LeBeaut United States
Amy O. Johnson‐Levonas United States
Jonathan L. Isaacsohn United States
Christine McCrary Sisk United States
Valerie A. Cain United States
Leslie Lipka United States
Elinor Miller relative to James W. Blasetto United States James W. Blasetto's profile →
Citations per field
00.5×1.7×
James W. Blasetto · 1×
Citations per year

Countries citing papers authored by Elinor Miller

Since Specialization
Citations

This map shows the geographic impact of Elinor Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elinor Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elinor Miller more than expected).

Fields of papers citing papers by Elinor Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elinor Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elinor Miller. The network helps show where Elinor Miller may publish in the future.

Co-authorship network of co-authors of Elinor Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Elinor Miller. A scholar is included among the top collaborators of Elinor Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elinor Miller. Elinor Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 5
2 74
3 33
4 2
5 0
6 1
7 5
8 50
9 87
10 7
11 66
12 32
13 24
14 89
15
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)breakdown →
1092
16 136
17 8
18 21
19 5

About Elinor Miller

Elinor Miller is a scholar working on Cancer Research, Surgery and Endocrinology, Diabetes and Metabolism, having authored 19 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (567 citations), Surgery (1.4k citations) and Cancer Research (352 citations). Elinor Miller has collaborated with scholars based in United States, Norway and United Kingdom. Frequent co-authors include Evan A. Stein, Harold Bays, James M. McKenney, James W. Blasetto, Peter H. Jones, Michael H. Davidson, Valerie A. Cain, J. Ycas, Rohini Chitra and David Hassman. Their work appears in journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026